Anthony J. Polverino is Chief Scientific Officer of Zymeworks Inc.. Currently has a direct ownership of 36,407 shares of ZYME, which is worth approximately $504,965. The most recent transaction as insider was on Jan 07, 2022, when has been sold 74 shares (Common Shares) at a price of $13.94 per share, resulting in proceeds of $1,032. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.4K
0% 3M change
0% 12M change
Total Value Held $504,965

Anthony J. Polverino Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 07 2022
BUY
Grant, award, or other acquisition
$1,032 $13.94 p/Share
74 Added 0.2%
36,407 Common Shares
Aug 31 2021
BUY
Exercise of conversion of derivative security
$73,500 $15.0 p/Share
4,900 Added 11.88%
36,333 Common Shares
Jul 06 2021
BUY
Grant, award, or other acquisition
$13,388 $29.49 p/Share
454 Added 1.42%
31,433 Common Shares
Mar 10 2021
SELL
Open market or private sale
$36,628 $34.95 p/Share
1,048 Reduced 3.27%
30,979 Common Shares
Mar 10 2021
BUY
Exercise of conversion of derivative security
-
2,500 Added 7.24%
32,027 Common Shares
Jan 07 2021
BUY
Grant, award, or other acquisition
$1,484 $30.92 p/Share
48 Added 0.16%
29,527 Common Shares

Also insider at

BCLI
BRAINSTORM CELL THERAPEUTICS INC. Healthcare
AJP

Anthony J. Polverino

Chief Scientific Officer
Vancouver, A1

Track Institutional and Insider Activities on ZYME

Follow Zymeworks Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZYME shares.

Notify only if

Insider Trading

Get notified when an Zymeworks Inc. insider buys or sells ZYME shares.

Notify only if

News

Receive news related to Zymeworks Inc.

Track Activities on ZYME